High performance plasma amyloid-β biomarkers for Alzheimer’s disease

Akinori Nakamura; Naoki Kaneko; Victor L. Villemagne; Takashi Kato; James D. Doecke; Vincent Doré; Christopher Fowler; Qiao‐Xin Li; Ralph N. Martins; Christopher C. Rowe; Taisuke Tomita; Katsumi Matsuzaki; Kenji Ishii; Kazunari Ishii; Yutaka Arahata; Shinichi Iwamoto; Kengo Ito; Koichi Tanaka; Colin L. Masters; Katsuhiko Yanagisawa

doi:10.1038/nature25456

Keywords

BiomarkerAmyloid (mycology)Pittsburgh compound BPositron emission tomographyDiseaseMedicineAlzheimer's diseaseCerebrospinal fluidAlzheimer's Disease Neuroimaging InitiativeNeuroimagingOncologyPathologyAmyloid precursor proteinInternal medicineNuclear medicineChemistryBiochemistryPsychiatry

MeSH Terms

AgedAlzheimer DiseaseAmyloid beta-PeptidesAmyloid beta-Protein PrecursorAustraliaBiomarkersBrainCase-Control StudiesCognitive DysfunctionCost-Benefit AnalysisFemaleHumansImmunoprecipitationJapanMaleMass SpectrometryPeptide FragmentsPositron-Emission TomographyReproducibility of Results

Affiliated Institutions

Related Publications

Clinicopathologic and<sup>11</sup>C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum

Melissa E. Murray , Val J. Lowe , Neill R. Graff‐Radford +12 more

Thal amyloid phase, which describes the pattern of progressive amyloid-β plaque deposition in Alzheimer's disease, was incorporated into the latest National Institute of Ageing ...

2015 Brain 324 citations

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ <sub>42</sub> in humans

Anne M. Fagan , Mark A. Mintun , Robert H. Mach +10 more

Abstract Objectives Amyloid‐β 42 (Aβ 42 ) appears central to Alzheimer's disease (AD) pathogenesis and is a major component of amyloid plaques. Mean cerebrospinal fluid (CSF) Aβ...

2005 Annals of Neurology 1238 citations

Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer’s disease

Peter Parbo , Rola Ismail , Kim Vang Hansen +15 more

See Kreisl (doi:10.1093/awx151) for a scientific commentary on this article.Subjects with mild cognitive impairment associated with cortical amyloid-β have a greatly increased r...

2017 Brain 185 citations

Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer’s Disease

Anne M. Fagan , Chengjie Xiong , Mateusz S. Jasielec +18 more

Longitudinal cerebrospinal fluid biomarker analyses reveal decreases in neuronal injury markers in later stages of autosomal-dominant Alzheimer’s disease.

2014 Science Translational Medicine 422 citations

Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline

Scott Ayton , Amir Fazlollahi , Pierrick Bourgeat +16 more

See Derry and Kent (doi:10.1093/awx167) for a scientific commentary on this article.The large variance in cognitive deterioration in subjects who test positive for amyloid-β by ...

2017 Brain 265 citations

Publication Info

Year: 2018
Type: article
Volume: 554
Issue: 7691
Pages: 249-254
Citations: 1587
Access: Closed

External Links

Download PDF (Free) View on DOI.org PubMed Semantic Scholar

Social Impact

Altmetric

High performance plasma amyloid-β biomarkers for Alzheimer’s disease

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1587

OpenAlex

Influential

Cite This

APA Style

                            
                                
                                    Akinori Nakamura, 
                                
                                    Naoki Kaneko, 
                                
                                    Victor L. Villemagne
                                
                                et al.
                            
                            (2018). 
                            High performance plasma amyloid-β biomarkers for Alzheimer’s disease. 
                            Nature
                            , 554
                            (7691)
                            , 249-254.
                            https://doi.org/10.1038/nature25456
                        

Identifiers

DOI: 10.1038/nature25456
PMID: 29420472

Data Quality

Data completeness: 72%